SCHEMBL30907484

SCHEMBL30907484

CCC(=O)c1cc(C)c(-c2cc3cnc(NC(=O)OC(C)(C)C)cc3nc2C(=O)OC)cn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.36
DYRK1A Q13627 1/20 0.36
FGFR1 P11362 4/20 0.35
SRC P12931 1/20 0.35
ABL1 P00519 7/20 0.34
RAF1 P04049 4/20 0.34
BRAF P15056 4/20 0.34
KRAS P01116 3/20 0.34
KDR P35968 3/20 0.34
MAP2K2 P36507 2/20 0.34
MAP2K1 Q02750 2/20 0.34
ARAF P10398 1/20 0.33
MAP4K1 Q92918 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.32
CDK9 P50750 1/20 0.32
LCK P06239 1/20 0.32
FLT1 P17948 1/20 0.32
FGFR2 P21802 1/20 0.32
FGFR4 P22455 1/20 0.32
FGFR3 P22607 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30907087 0.90 GSK3B (0.35) GSK3BDYRK1AFGFR1SRCABL1
SCHEMBL30907335 0.84 ABL1 (0.38) GSK3BDYRK1AFGFR1SRCABL1
SCHEMBL30907378 0.83 GSK3B (0.42) GSK3BDYRK1AABL1MAP4K1IRAK4
SCHEMBL30907430 0.83 ABL1 (0.34) ABL1
SCHEMBL30907102 0.81 FGFR1 (0.41) FGFR1SRCABL1
SCHEMBL30907084 0.81 GSK3B (0.36) GSK3BDYRK1AFGFR1ABL1RAF1
SCHEMBL30907334 0.80 ABL1 (0.46) GSK3BDYRK1AABL1MAP4K1
SCHEMBL30907302 0.80 MKNK2 (0.37) GSK3BDYRK1AFGFR1SRCABL1
SCHEMBL24666550 0.79 GSK3B (0.40) GSK3BDYRK1AFGFR1SRCABL1
SCHEMBL30907294 0.78 ABL1 (0.57) GSK3BDYRK1AABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024097953-A1 NAPHTHYRIDINE COMPOUNDS FOR INHIBITION OF RAF KINASES ENLIVEN INC. (US) 2024-05-10 WO disclosed